8-(4-((2-aminoethyl)aminocarbonylmethyloxy)phenyl)-1,3-dipropylxanthine has been researched along with adenosine in 40 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (12.50) | 18.7374 |
| 1990's | 28 (70.00) | 18.2507 |
| 2000's | 5 (12.50) | 29.6817 |
| 2010's | 2 (5.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Gobran, LI; Griese, M; Rooney, SA | 3 |
| Klotz, KN; Lehr, HA; Lorenzen, A; Messmer, K; Nolte, D; Zimmer, FJ | 1 |
| Baumgold, J; Jacobson, KA; Nikodijevic, O | 1 |
| Jacobson, KA; Ji, XD; Stiles, GL; van Galen, PJ | 1 |
| Jacobson, KA; Ji, XD; Stiles, GL | 1 |
| Green, RD; Jacobson, KA; Leung, E | 1 |
| Holtzman, SG; Mante, S; Minneman, KP | 1 |
| Bealer, SL; Proctor, KG; Stojanov, I | 1 |
| Klotz, KN; Lohse, MJ; Schwabe, U | 1 |
| Itahashi, Y; Murayama, T; Nomura, Y | 1 |
| Olah, M; Stiles, GL | 1 |
| Green, RD; Leung, E | 1 |
| Barone, S; Churchill, PC; Jacobson, KA | 1 |
| Prostran, M; Varagić, VM | 1 |
| Churchill, MC; Churchill, PC; Jacobson, KA | 1 |
| Churchill, PC; Jacobson, KA; Leahy, AE; Rossi, NF | 1 |
| Carter, MF; Jacobson, KA; Lin, RC; Popik, P; Von Lubitz, DK | 1 |
| Nakata, H; Saitoh, O; Saitoh, Y | 1 |
| Basavappa, S; Fitz, JG; Mangel, AW; McGill, JM; Middleton, JP; Shimokura, GH | 1 |
| Berne, RM; Linden, J; Sawmiller, DR | 1 |
| el-Sawalhi, MM; Ismail, NA; Megahed, YM; Shaheen, AA | 1 |
| Currin, RT; Lemasters, JJ; Lichtman, SN; Reinstein, LJ; Thurman, RG; Wang, J | 1 |
| Balcells, E; Rubio, R; Suarez, J | 1 |
| Nakamura, S; Ohshita, T; Sawamoto, N; Yamashita, H; Zhang, YX | 1 |
| Dobson, JG; Fenton, RA; Sawmiller, DR | 1 |
| Glashofer, M; Jacobson, KA; Jiang, Q; Lee, BX; van Rhee, AM | 1 |
| Fredholm, BB; Hegler, J; Hessling, J; Klotz, KN; Kull, B; Lohse, MJ; Owman, C | 1 |
| Dahms, TE; Pearse, DB; Wagner, EM | 1 |
| Richardt, G; Schreieck, J | 1 |
| Hazeki, O; Katada, T; Takasuga, S; Ui, M | 1 |
| Broussas, M; Cornillet-Lefèbvre, P; Nguyen, P; Potron, G | 1 |
| Murrant, CL; Sarelius, IH | 1 |
| Bourgoin, S; Cesselin, F; Hamon, M; Mauborgne, A; Poliénor, H | 1 |
| Fujii, Y; Nomura, T; Okamoto, K; Shinoda, S; Yokoyama, R | 1 |
| Choi, JW; Ko, KH; Yoo, BK; Yoon, SY | 1 |
| Briddon, SJ; Bridge, LJ; Hill, SJ; May, LT; Stoddart, LA | 1 |
| Anderson, AS; Khan, IU; Loza, MJ; O'Rourke, KS; Wood, J | 1 |
40 other study(ies) available for 8-(4-((2-aminoethyl)aminocarbonylmethyloxy)phenyl)-1,3-dipropylxanthine and adenosine
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Cibacron blue stimulation of surfactant secretion in rat type II pneumocytes.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Cyclic AMP; L-Lactate Dehydrogenase; Lung; Phosphatidylcholines; Protein Synthesis Inhibitors; Pulmonary Surfactants; Rats; Second Messenger Systems; Stimulation, Chemical; Suramin; Terbutaline; Triazines; Xanthines | 1992 |
Reduction of postischemic leukocyte-endothelium interaction by adenosine via A2 receptor.
Topics: Adenosine; Animals; Cell Adhesion; Cricetinae; Endothelium, Vascular; Ischemia; Leukocytes; Mesocricetus; Muscles; Phenethylamines; Receptors, Purinergic; Reperfusion Injury; Thioinosine; Xanthines | 1992 |
Penetration of adenosine antagonists into mouse brain as determined by ex vivo binding.
Topics: Adenosine; Animals; Brain Chemistry; Cerebrovascular Circulation; Injections, Intraperitoneal; Locomotion; Male; Mice; Receptors, Purinergic; Theophylline; Time Factors; Xanthines | 1992 |
Characterization of human striatal A2-adenosine receptors using radioligand binding and photoaffinity labeling.
Topics: Adenosine; Affinity Labels; Aged; Corpus Striatum; Guanosine Triphosphate; Humans; Male; Phenethylamines; Radioligand Assay; Receptors, Purinergic; Xanthines | 1992 |
Chemical modification and irreversible inhibition of striatal A2a adenosine receptors.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Affinity Labels; Amino Acid Sequence; Animals; Corpus Striatum; Diethyl Pyrocarbonate; Drug Antagonism; Hydroxylamine; Hydroxylamines; Molecular Sequence Data; Phenethylamines; Purinergic Antagonists; Rabbits; Radioligand Assay; Receptors, Purinergic; Theophylline; Xanthines | 1992 |
A2 and P2 purine receptor interactions and surfactant secretion in primary cultures of type II cells.
Topics: Adenosine; Adenosine Diphosphate; Adenosine Triphosphate; Adenosine-5'-(N-ethylcarboxamide); AMP Deaminase; Animals; Cells, Cultured; Cyclic AMP; Inositol 1,4,5-Trisphosphate; Lung; Phosphatidylcholines; Pulmonary Surfactants; Receptors, Purinergic; Terbutaline; Theophylline; Thionucleotides; Xanthines | 1991 |
Apparent heterogeneity of cardiac A1 adenosine receptors as revealed by radioligand binding experiments on N-ethylmaleimide-treated membranes.
Topics: Adenosine; Animals; Binding Sites; Cattle; Cell Membrane; Cerebral Cortex; Ethylmaleimide; Heart; Myocardium; Radioligand Assay; Receptors, Purinergic; Xanthines | 1991 |
Role of adenosine receptors in caffeine tolerance.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Administration, Oral; Animals; Binding Sites; Brain; Caffeine; Cyclic AMP; Drug Administration Schedule; Drug Interactions; Drug Tolerance; Male; Motor Activity; Phenylisopropyladenosine; Rats; Rats, Inbred Strains; Receptors, Purinergic; Time Factors; Tritium; Xanthines | 1991 |
Activation of brain adenosine receptors evokes vasodilation in skin arterioles.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Arterioles; Brain; Cricetinae; Injections, Intraventricular; Male; Mesocricetus; Receptors, Purinergic; Skin; Theophylline; Vasodilation; Vasodilator Agents; Xanthines | 1991 |
Mechanism of A2 adenosine receptor activation. I. Blockade of A2 adenosine receptors by photoaffinity labeling.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Adenylyl Cyclases; Alprostadil; Azides; Blood Platelets; Humans; Kinetics; Membranes; Phenylisopropyladenosine; Purinergic Antagonists; Radioligand Assay; Receptors, Purinergic; Tritium; Vasodilator Agents; Xanthines | 1991 |
Possible involvement of pertussis toxin-sensitive G proteins and D2 dopamine receptors in the A1 adenosine receptor-adenylate cyclase system in rat cerebral cortex.
Topics: Adenosine; Adenylate Cyclase Toxin; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Animals; Apomorphine; Cerebral Cortex; GTP-Binding Proteins; Male; Pertussis Toxin; Phenylisopropyladenosine; Quinuclidinyl Benzilate; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Purinergic; Virulence Factors, Bordetella; Xanthines | 1990 |
Agonists and antagonists recognize different but overlapping populations of A1 adenosine receptors: modulation of receptor number by MgCl2, solubilization, and guanine nucleotides.
Topics: Adenosine; Animals; Cattle; Cell Membrane; Cerebral Cortex; Guanosine Triphosphate; Guanylyl Imidodiphosphate; Kinetics; Magnesium Chloride; Phenylisopropyladenosine; Rats; Rats, Inbred Strains; Receptors, Purinergic; Ultracentrifugation; Xanthines | 1990 |
Density gradient profiles of A1 adenosine receptors labeled by agonist and antagonist radioligands before and after detergent solubilization.
Topics: Adenosine; Adenosine Deaminase; Animals; Cattle; Cell Membrane; Centrifugation, Density Gradient; Cerebral Cortex; Ethylmaleimide; GTP-Binding Proteins; Guanosine Triphosphate; Guanylyl Imidodiphosphate; Iodobenzenes; Ligands; Macromolecular Substances; Receptors, Purinergic; Solubility; Xanthines | 1989 |
Adenosine receptor prodrugs: towards kidney-selective dialkylxanthines.
Topics: Adenosine; Animals; Blood Pressure; Brain; Glomerular Filtration Rate; Heart Rate; Indicators and Reagents; Kidney; Kinetics; Male; Potassium; Prodrugs; Rats; Rats, Inbred Strains; Receptors, Purinergic; Reference Values; Sodium; Structure-Activity Relationship; Xanthines | 1989 |
The effect of 5'-N-ethylcarboxamideadenosine on the isolated hemidiaphragm of the rat during direct and indirect electrical stimulation.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Aminophylline; Animals; Diaphragm; Dipyridamole; Electric Stimulation; Female; In Vitro Techniques; Isometric Contraction; Male; Neuromuscular Blocking Agents; Rats; Receptors, Purinergic; Respiratory Muscles; Tubocurarine; Xanthines | 1989 |
XAC, a functionalized congener of 1,3-dialkylxanthine, antagonizes A1 adenosine receptor-mediated inhibition of renin secretion in vitro.
Topics: Adenosine; Animals; In Vitro Techniques; Kidney Cortex; Male; Rats; Rats, Inbred Strains; Receptors, Purinergic; Renin; Xanthines | 1987 |
Further characterization of the renovascular effects of N6-cyclohexyladenosine in the isolated perfused rat kidney.
Topics: Adenosine; Animals; In Vitro Techniques; Kidney; Male; Perfusion; Rats; Rats, Inbred Strains; Renal Circulation; Theophylline; Vasoconstriction; Xanthines | 1987 |
Adenosine A3 receptor stimulation and cerebral ischemia.
Topics: Adenosine; Animals; Blood Pressure; Brain Ischemia; Cerebrovascular Circulation; Drug Administration Schedule; Female; Gerbillinae; Neurons; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Xanthines | 1994 |
Regulation of A2a adenosine receptor mRNA expression by agonists and forskolin in PC12 cells.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Colforsin; Cyclic AMP; Gene Expression Regulation, Neoplastic; PC12 Cells; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Receptors, Purinergic P1; RNA, Messenger; Second Messenger Systems; Xanthines | 1994 |
Adenosine triphosphate activates ion permeabilities in biliary epithelial cells.
Topics: Adenosine; Adenosine Triphosphate; Adenosine-5'-(N-ethylcarboxamide); Animals; Bile Duct Neoplasms; Bile Ducts; Calcium; Cell Membrane Permeability; Cells, Cultured; Chlorides; Cholangiocarcinoma; Humans; Iodine Radioisotopes; Ion Transport; Male; Potassium; Rats; Rats, Sprague-Dawley; Rubidium Radioisotopes; Tumor Cells, Cultured; Uridine Triphosphate; Xanthines | 1994 |
Effects of xanthine amine congener on hypoxic coronary resistance and venous and epicardial adenosine concentrations.
Topics: Adenosine; Animals; Chromatography, High Pressure Liquid; Coronary Vessels; Guinea Pigs; Hypoxia; Male; Perfusion; Pericardium; Radioligand Assay; Vascular Resistance; Vasodilation; Xanthines | 1994 |
Combined effect of adenosine, alpha adrenergic and adenosine antagonists on serum insulin and insulin secretion from rat pancreatic islets.
Topics: Adenosine; Animals; Drug Interactions; Female; Glucose; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Prazosin; Rats; Rats, Wistar; Theophylline; Xanthines; Yohimbine | 1994 |
Suppression of lipopolysaccharide-stimulated release of tumor necrosis factor by adenosine: evidence for A2 receptors on rat Kupffer cells.
Topics: Adenosine; Alprostadil; Animals; Bucladesine; Cells, Cultured; Cyclic AMP; Kupffer Cells; Lipopolysaccharides; Nisoldipine; Quinazolines; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Triazoles; Tumor Necrosis Factor-alpha; Xanthines | 1994 |
Implications of the coronary vascular endothelium as mediator of the vasodilatory and dromotropic actions of adenosine.
Topics: Adenosine; Animals; Endothelium, Vascular; Guinea Pigs; Hypoxia; Male; Microscopy, Electron; Microspheres; Nerve Fibers; Neural Conduction; Vasodilation; Xanthines | 1993 |
Signal-transduction mechanisms of ATP-stimulated phosphatidylcholine secretion in rat type II pneumocytes: interactions between ATP and other surfactant secretagogues.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine; Adenosine Triphosphate; Adenosine-5'-(N-ethylcarboxamide); Animals; Cells, Cultured; Drug Interactions; Ionomycin; Isoquinolines; L-Lactate Dehydrogenase; Lung; Male; Phosphatidylcholines; Piperazines; Rats; Rats, Sprague-Dawley; Signal Transduction; Sulfonamides; Terbutaline; Tetradecanoylphorbol Acetate; Xanthines | 1993 |
ATP induces release of newly synthesized dopamine in the rat striatum.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; alpha-Methyltyrosine; Animals; Calcium; Calcium Channel Blockers; Calcium Channels; Corpus Striatum; Dopamine; Homovanillic Acid; Kinetics; Male; Methyltyrosines; Microdialysis; Neurons; omega-Conotoxin GVIA; Peptides; Purinergic P2 Receptor Antagonists; Rats; Rats, Wistar; Reserpine; Suramin; Tetrodotoxin; Xanthines | 1996 |
Myocardial adenosine A1 and A2 receptor activities during juvenile and adult stages of development.
Topics: Adenosine; Aging; Animals; Coronary Vessels; Drug Synergism; Heart; Isoproterenol; Male; Myocardial Contraction; Myocardium; Osmolar Concentration; Purinergic P1 Receptor Antagonists; Quinazolines; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Triazoles; Veins; Xanthines | 1996 |
Mutagenesis reveals structure-activity parallels between human A2A adenosine receptors and biogenic amine G protein-coupled receptors.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Affinity Labels; Animals; COS Cells; Enzyme-Linked Immunosorbent Assay; GTP-Binding Proteins; Humans; Hydrogen-Ion Concentration; Iodobenzenes; Ligands; Models, Chemical; Models, Molecular; Mutagenesis, Site-Directed; Phenethylamines; Purinergic P1 Receptor Agonists; Rats; Receptor, Adenosine A2A; Receptors, Biogenic Amine; Receptors, Purinergic P1; Structure-Activity Relationship; Xanthines | 1997 |
Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Base Composition; Binding, Competitive; CHO Cells; Cricetinae; Guanylate Cyclase; Humans; Phenethylamines; Phenylisopropyladenosine; Receptors, Purinergic P1; Stereoisomerism; Structure-Activity Relationship; Transfection; Xanthines | 1998 |
Microsphere-induced bronchial artery vasodilation: role of adenosine, prostacyclin, and nitric oxide.
Topics: Adenine Nucleotides; Adenosine; Animals; Bronchial Arteries; Dipyridamole; Enzyme Inhibitors; Epoprostenol; Lactic Acid; Microspheres; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Sheep; Vasodilation; Xanthines | 1998 |
Endogenous adenosine reduces the occurrence of ischemia-induced ventricular fibrillation in rat heart.
Topics: Adenine; Adenosine; Aminoimidazole Carboxamide; Animals; Caffeine; Creatine Kinase; Electrocardiography; Enzyme Inhibitors; Hypoxanthine; Inosine; Male; Myocardial Ischemia; Myocardium; Perfusion; Rats; Rats, Wistar; Reperfusion Injury; Ribonucleosides; Theophylline; Thioinosine; Thiophenes; Time Factors; Ventricular Fibrillation; Xanthines | 1999 |
Enhancement by adenosine of insulin-induced activation of phosphoinositide 3-kinase and protein kinase B in rat adipocytes.
Topics: Adenosine; Adenosine Deaminase; Adipocytes; Animals; Dideoxyadenosine; Dinoprostone; Enzyme Activation; Insulin; Male; Phenylisopropyladenosine; Phosphatidylinositol 3-Kinases; Phosphatidylinositol Phosphates; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Second Messenger Systems; Xanthines | 1999 |
Inhibition of fMLP-triggered respiratory burst of human monocytes by adenosine: involvement of A3 adenosine receptor.
Topics: Adenosine; Bucladesine; Calcium; Carbazoles; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cytochalasin B; Enzyme Activation; Enzyme Inhibitors; Flow Cytometry; Humans; Indoles; Luminescent Measurements; Monocytes; N-Formylmethionine Leucyl-Phenylalanine; NADPH Oxidases; Oxygen Consumption; Pyrroles; Receptor, Adenosine A3; Receptors, Purinergic P1; Respiratory Burst; RNA, Messenger; Second Messenger Systems; Theobromine; Xanthines | 1999 |
Multiple dilator pathways in skeletal muscle contraction-induced arteriolar dilations.
Topics: Adenosine; Adenosine Triphosphate; Animals; Anti-Arrhythmia Agents; Arterioles; Cricetinae; Enzyme Inhibitors; Glyburide; Male; Mesocricetus; Muscle Contraction; Muscle, Skeletal; Nitric Oxide; Nitroarginine; Potassium Channels; Receptors, Purinergic P1; Vasodilation; Xanthines | 2002 |
Adenosine receptor-mediated control of in vitro release of pain-related neuropeptides from the rat spinal cord.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Calcitonin Gene-Related Peptide; Cholecystokinin; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Neuropeptides; Pain; Phenethylamines; Potassium; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Spinal Cord; Substance P; Xanthines | 2002 |
Studies of the mechanism of action of the aerolysin-like hemolysin of Aeromonas sobria in stimulating T84 cells to produce cyclic AMP.
Topics: Adenosine; Adenosine Deaminase; Adenosine Triphosphate; Aeromonas; Bacterial Toxins; Cell Line; Colon; Cyclic AMP; Hemolysin Proteins; Humans; Pore Forming Cytotoxic Proteins; Xanthines | 2003 |
Protective effect of adenosine and purine nucleos(t)ides against the death by hydrogen peroxide and glucose deprivation in rat primary astrocytes.
Topics: Adenine; Adenosine; Analysis of Variance; Animals; Animals, Newborn; Astrocytes; Benzimidazoles; Carbocyanines; Cell Death; Cells, Cultured; Dose-Response Relationship, Drug; Drug Interactions; Glucose; Hydrogen Peroxide; In Vitro Techniques; L-Lactate Dehydrogenase; Membrane Potentials; Mitochondria; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Purines; Rats; Rats, Sprague-Dawley; Theobromine; Thioinosine; Time Factors; Xanthines | 2005 |
Allosteric interactions across native adenosine-A3 receptor homodimers: quantification using single-cell ligand-binding kinetics.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Allosteric Regulation; Animals; CHO Cells; Cricetinae; Cricetulus; Gene Expression Regulation; Humans; Kinetics; Protein Binding; Receptor, Adenosine A3; Xanthines | 2011 |
T-cell specific defect in expression of the NTPDase CD39 as a biomarker for lupus.
Topics: Adenosine; Adult; Aged; Antigens, CD; Apyrase; Biomarkers; Cell Proliferation; Cells, Cultured; Flow Cytometry; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Middle Aged; T-Lymphocytes; T-Lymphocytes, Regulatory; Xanthines | 2011 |